Conditions or Focus of Study: B7-H3 Positive Relapsed/Advanced Malignant Solid Tumor

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Conditions or Focus of Study: B7-H3 Positive Relapsed/Advanced Malignant Solid Tumor trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

CompletedPhase 1

NCT06372236

UTAA06 Injection for Treatment of Advanced Malignant Solid Tumors

This is a single-arm, open, early-stage clinical study. The main purpose of this study is to explore the maximum tolerated dose (MTD), the optimal phase II reco…

China10 participantsStarted 2023-12-05

Treatment: UTAA06 injection for treatment of advanced malignant solid tumors